Legal & General Group
CRBP icon

Legal & General Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Legal & General Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,103
Closed -$5.86K – 3442
2025
Q1 		$5.86K Hold
1,103
– – ﹤0.01% 3255
2024
Q4 		$13K Hold
1,103
– – ﹤0.01% 3184
2024
Q3 		$22.8K Buy
1,103
+75
+7% +$3.84K ﹤0.01% 3004
2024
Q2 		$46.5K Buy
+1,028
New +$43.2K ﹤0.01% 2808
2021
Q2 		– Sell
-273
Closed -$16K – 3523
2021
Q1 		$16K Hold
273
– – ﹤0.01% 3211
2020
Q4 		$10K Sell
273
-93
-25% -$3.48K ﹤0.01% 3333
2020
Q3 		$20K Sell
366
-90
-20% -$16.3K ﹤0.01% 2962
2020
Q2 		$114K Buy
456
+98
+27% +$19.8K ﹤0.01% 2492
2020
Q1 		$56K Sell
358
-40
-10% -$6.76K ﹤0.01% 2556
2019
Q4 		$65K Buy
398
+80
+25% +$11.8K ﹤0.01% 2722
2019
Q3 		$46K Hold
318
– – ﹤0.01% 2764
2019
Q2 		$66K Hold
318
– – ﹤0.01% 2668
2019
Q1 		$66K Buy
318
+44
+16% +$9.7K ﹤0.01% 2621
2018
Q4 		$48K Buy
274
+35
+15% +$6.99K ﹤0.01% 2706
2018
Q3 		$54K Hold
239
– – ﹤0.01% 2731
2018
Q2 		$36K Sell
239
-49
-17% -$8.9K ﹤0.01% 2913
2018
Q1 		$52K Sell
288
-100
-26% -$22.5K ﹤0.01% 2734
2017
Q4 		$83K Sell
388
-93
-19% -$19.9K ﹤0.01% 2673
2017
Q3 		$104K Buy
481
+69
+17% +$13.5K ﹤0.01% 2622
2017
Q2 		$77K Buy
+412
New +$80.8K ﹤0.01% 2737

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Legal & General Group's CRBP Position: Q2 2025 in Review

Legal & General Group sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 1,103 shares — an estimated $5.86K sold.

Legal & General Group first reported a position in CRBP in Q2 2017 and held it in 20 quarters. The position peaked at $114K in Q2 2020. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Legal & General Group reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 1,103 Corbus Pharmaceuticals shares in Q2 2025, an estimated $5.86K.
  • Legal & General Group first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 20 quarters.
  • Legal & General Group's Corbus Pharmaceuticals position peaked at $114K in Q2 2020.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.